In a report released today, Andrew Cooper from Raymond James maintained a Buy rating on Invitae (NVTA – Research Report), with a price target of $10.50. The company's shares closed last Thursday at $6.50, close to its 52-week low of $6.06. According to TipRanks.com, Cooper is ranked 0 out of 5 stars with an average return of -17.8% and a 22.5% success rate. Cooper covers the Healthcare sector, focusing on stocks such as Exact Sciences, NeoGenomics, and Progenity. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Invitae with a $17.13 average price target, which is a 141.9% upside from current levels.
https://www.tipranks.com/news/blurbs/raymond-james-thinks-invitaes-stock-is-going-to-recover-2?utm_source=advfn.com&utm_medium=referral
Invitae (NYSE:NVTA)
Historical Stock Chart
From Jul 2022 to Aug 2022 Click Here for more Invitae Charts.
Invitae (NYSE:NVTA)
Historical Stock Chart
From Aug 2021 to Aug 2022 Click Here for more Invitae Charts.